Travers Smith LLP has advised client SV Health Managers LLP in relation to the recent closing of Dementia Discovery LP. DDF Investors admitted to the DDF at the closing include Bill Gates, who has committed a $50 million investment, resulting in the current total commitments from investors exceeding the original target of £130 million.
The Fund, which launched in October 2015, is managed by SV Health Managers LLP, and is focused entirely on discovering and developing novel therapies for dementia. It was formed through the collaboration of the UK Department of Health, several leading pharmaceutical companies and the charity Alzheimer’s Research UK.
The Travers Smith team was led by Head of Investment Funds, Sam Kay and also included Investment Funds Associate Eilidh Campbell. Tax advice was given by Tax Partner Elena Rowlands with support from Tax Associate Joseph Sheldrick.